Overview
Status
Active
Registry date
2023-10-02
Share capital
5,000.00 PLN
Registered address
ul. Ludwika Zamenhofa 29/U3, 15-435 Białystok, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Aidas Štelmokas – Management Board Member
Nojus Arnoldas Milinis – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Nojus Arnoldas Milinisage 28 | 50 | $675.31 | 50% |
Aidas Štelmokasage 53 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Wstechnologysp. z o.o. | $258,318.71 | wstechnology.pl | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Plan Biosp. z o.o. | $3,404.49 | biotrem.pl | ||
| Aiventrosp. z o.o. | $0.00 | aiventro.com | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
FAQ
The main business activity of Vertex Technologies focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 2, 2023.
The headquarters is located at: ul. Ludwika Zamenhofa 29, 15-435 Białystok.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-26